Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.

por Scheithauer, W., Schenk, T., Czejka, M.
Publicado 1993

HER 2/neu protein expression in colorectal cancer

por Schuell, B, Gruenberger, T, Scheithauer, W, Zielinski, Ch, Wrba, F
Publicado 2006

Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours.

por Kornek, G., Schenk, T., Raderer, M., Djavarnmad, M., Scheithauer, W.
Publicado 1995

Human colon cancer cell lines secrete alpha TGF-like activity.

por Hanauske, A. R., Buchok, J., Scheithauer, W., Von Hoff, D. D.
Publicado 1987

MDR1 gene expression in primary colorectal carcinomas.

por Pirker, R., Wallner, J., Gsur, A., Götzl, M., Zöchbauer, S., Scheithauer, W., Depisch, D.
Publicado 1993

123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer.

por Raderer, M., Kurtaran, A., Hejna, M., Vorbeck, F., Angelberger, P., Scheithauer, W., Virgolini, I.
Publicado 1998

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

por Bernhard, J, Dietrich, D, Glimelius, B, Hess, V, Bodoky, G, Scheithauer, W, Herrmann, R
Publicado 2010

Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer.

por Hejna, M., Kornek, G. V., Raderer, M., Depisch, D., Brodowicz, T., Fiebiger, W. C., Scheithauer, W.
Publicado 1998

Side effects during chemotherapy predict tumour response in advanced colorectal cancer

por Schuell, B, Gruenberger, T, Kornek, G V, Dworan, N, Depisch, D, Lang, F, Schneeweiss, B, Scheithauer, W
Publicado 2005

Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.

por Virgolini, I., Kornek, G., Höbart, J., Li, S. R., Raolerer, M., Bergmann, H., Scheithauer, W., Pantev, T., Angelberger, P., Sinzinger, H.
Publicado 1993

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

por Cassidy, J, Clarke, S, Díaz-Rubio, E, Scheithauer, W, Figer, A, Wong, R, Koski, S, Rittweger, K, Gilberg, F, Saltz, L
Publicado 2011

Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.

por Kornek, G. V., Haider, K., Kwasny, W., Hejna, M., Raderer, M., Meghdadi, S., Burger, D., Schneeweiss, B., Depisch, D., Scheithauer, W.
Publicado 1996

Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.

por Kornek, G. V., Haider, K., Kwasny, W., Lang, F., Krauss, G., Hejna, M., Raderer, M., Weinländer, G., Depisch, D., Scheithauer, W.
Publicado 1998

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric...

por Kornek, G V, Raderer, M, Schüll, B, Fiebiger, W, Gedlicka, C, Lenauer, A, Depisch, D, Schneeweiss, B, Lang, F, Scheithauer, W
Publicado 2002

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

por Kornek, G V, Schratter-Sehn, A, Marczell, A, Depisch, D, Karner, J, Krauss, G, Haider, K, Kwasny, W, Locker, G, Scheithauer, W
Publicado 2000

Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

por Scheithauer, W, Kornek, G V, Raderer, M, Hejna, M, Valencak, J, Miholic, J, Kovats, E, Lang, F, Funovics, J, Bareck, E, Depisch, D
Publicado 1999

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

por André, T, Reyes-Vidal, J M, Fartoux, L, Ross, P, Leslie, M, Rosmorduc, O, Clemens, M R, Louvet, C, Perez, N, Mehmud, F, Scheithauer, W
Publicado 2008

Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma

por Ulrich-Pur, H, Raderer, M, Verena Kornek, G, Schüll, B, Schmid, K, Haider, K, Kwasny, W, Depisch, D, Schneeweiss, B, Lang, F, Scheithauer, W
Publicado 2003

Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results

por Raderer, M, Hamilton, G, Kurtaran, A, Valencak, J, Haberl, I, Hoffmann, O, Kornek, G V, Vorbeck, F, Hejna, M H L, Virgolini, I, Scheithauer, W
Publicado 1999

Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.

por Scheithauer, W., Kornek, G. V., Marczell, A., Karner, J., Salem, G., Greiner, R., Burger, D., Stöger, F., Ritschel, J., Kovats, E., Vischer, H. M., Schneeweiss, B., Depisch, D.
Publicado 1998